Citations

Mayo Clinic

Showing 10 of 108551 citations.

An unusual case of metastatic trophoblastic neoplasm presenting with diffuse cystic lung disease and pulmonary artery pseudoaneurysms in a teenager
Guler, Sevim , Hull, Nathan C. , Arteta, Manuel , Shahi, Maryam , Ishitani, Michael B., Demirel, Nadir , Allen-Rhoades, Wendy, Guler, Sevim , Allen‐Rhoades, Wendy

Pediatric Pulmonology | February 23, 2024 | Volume: 59 | Issue: 5 | Pages: 1482-1486

10.1002/ppul.26936 | PMID 38390771 Get It

AbstractDiffuse cystic lung diseases (DCLDs) are a diverse group of lung disorders characterized by the presence of multiple air filled cysts within the lung tissue. These cysts are thin walled and surrounded by normal lung tissue. In adults, DCLD can be associated with various conditions such as lymphangioleiomyomatosis (LAM), Langerhans cell histiocytosis, cancers, and more. In children, DCLD is often linked to lung developmental abnormalities, with bronchopulmonary dysplasia being a common cause. Patients with pulmonary cysts are typically asymptomatic, but some may experience mild symptoms or pneumothorax. While DCLD in children is rarely due to malignancy, metastatic lung disease can be a cause. It is important for clinicians to be aware of the possibility of metastatic lung disease when encountering DCLD.
The Respiratory System
Bartman, Colleen M. , Prakash, Y. S.

Chronobiology and Chronomedicine | February 23, 2024 | Volume: No volume available | Issue: No issue available | Pages: 160-191

10.1039/bk9781839167553-00160 Get It

Rhythms in lung function and time-of-day-dependent exacerbation in disease symptoms have been noted dating back to the 5th century. Today, we recognize the 24-hour variation in normal lung function and how these fluctuations are associated with the circadian component of lung pathophysiology. Diseases of the airway such as allergic asthma, COPD, pulmonary fibrosis, pneumonia and sepsis, and lung cancer all have documented correlations with circadian rhythm and the peripheral molecular clock. Additionally, chronic exposure to particulate matter and other pollutants can induce alterations in clock genes/proteins, and disruption of the circadian system increases susceptibility to poor outcomes following insult to the airway. Investigations into targets of the molecular clock have shed light on chronotherapeutics that can be used to optimize therapeutic approaches in the clinic or leverage endogenous circadian networks to enhance efficacy of currently available treatments.
12 VITAMIN E IN THE TREATMENT OF WILSON'S DISEASE
Zeid, I, Perrault, Jean, Freese, Deborah K., Cox, D

Journal of Pediatric Gastroenterology and Nutrition | February 23, 2024 | Volume: 23 | Issue: 3 | Pages: 345-345

10.1002/j.1536-4801.1996.tb01595.x Get It

Behavioral Intervention for the Treatment of Rumination
Wagaman, Joel R., Williams, Donald E., Camilleri, Michael

Journal of Pediatric Gastroenterology and Nutrition | February 23, 2024 | Volume: 27 | Issue: 5 | Pages: 596-598

10.1002/j.1536-4801.1998.tb01979.x Get It

General Versus Nongeneral Anesthesia for Carotid Endarterectomy: A Prospective Multicenter Registry-Based Study on 25 000 Patients
El-Hajj, Victor Gabriel , Gharios, Maria , Atallah, Elias , Glener, Steven, Habashy, Karl J. , Hoang, Harry , Sizdahkhani, Saman , Kaul, Anand , Elmi‐Terander, Adrian , Tjoumakaris, Stavropoula , Rosenwasser, Robert H. , Jabbour, Pascal , Elmi-Terander, Adrian , El-Hajj, Victor Gabriel , Ghaith, Abdul Karim , Naamani, Kareem El , Mouchtouris, Nikolaos , Gooch, Michael Reid , Jabbour, Pascal

Neurosurgery | February 23, 2024 | Volume: 95 | Issue: 2 | Pages: 365-371

10.1227/neu.0000000000002887 | PMID 38391204 Get It

BACKGROUND AND OBJECTIVES: Carotid endarterectomy (CEA) is a well-established treatment option for carotid stenosis. The choice between general anesthesia (GA) and nongeneral anesthesia (non-GA) during CEA remains a subject of debate, with concerns regarding perioperative complications, particularly myocardial infarctions. This study aimed to evaluate the outcomes associated with GA vs non-GA CEA using a large, nationwide database. METHODS: The National Surgical Quality Improvement Project database was queried for patients undergoing CEA between 2013 and 2020. Primary outcome measures including surgical outcomes and 30-day postoperative complications were compared between the 2 anesthesia methods, after 2:1 propensity score matching. RESULTS: After propensity score matching, a total of 25 356 patients (16 904 in the GA and 8452 in the non-GA group) were included. Non-GA compared with GA CEA was associated with significantly shorter operative times (101.9, 95% CI: 100.5-103.3 vs 115.8 95% CI: 114.4-117.2 minutes, P < .001), reduced length of hospital stays (2.3, 95% CI: 2.15-2.4 vs 2.5, 95% CI: 2.4-2.6 days, P < .001), and lower rates of 30-day postoperative complications, including myocardial infarctions (0.8% vs 1.2%, P = .003), unplanned intubations (0.8% vs 1.1%, P = .016), pneumonia (0.5% vs 1%, P < .001), and urinary tract infections (0.4% vs 0.7%, P = .003). These outcomes were notably more pronounced in the younger (≤70 years) and high morbidity (American Society of Anesthesiologists 3-5) cohorts. CONCLUSION: In this nationwide registry-based study, non-GA CEA was associated with better short-term outcomes in terms of perioperative complications, compared with GA CEA. The findings suggest that non-GA CEA may be a safer alternative, especially in younger patients and those with more comorbidities.
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence
Luque, Laura F. Mendez , Avelar‐Barragan, Julio , Nguyen, Hellen , Nguyen, Jenny , Soyfer, Eli M. , Liu, Jiarui , Chen, Jane H. , Mehrotra, Nitya , Huang, Xin , Kosiorek, Heidi , Dueck, Amylou C. , Heide, Elena , Lem, Melinda , Alaoui, Kenza El , Mas, Eduard , Scherber, Robyn M. , Whiteson, Katrine , Dueck, A. C. , Mendez Luque, Laura F , Kosiorek, Heidi E , Himstead, Alexander , Heide, Elena , Lem, Melinda , El Alaoui, Kenza , Mas, Eduard , Scherber, Robyn M , Mesa, Ruben , Whiteson, Katrine L , Odegaard, Andrew , Fleischman, Angela G , Mesa, Ruben A. , Fleischman, Angela G.

Cancer Research Communications | February 23, 2024 | Volume: 4 | Issue: 3 | Pages: 660-670

10.1158/2767-9764.crc-23-0380 | PMID 38391189 Get It

Abstract Purpose: Chronic inflammation is integral to myeloproliferative neoplasm (MPN) pathogenesis. JAK inhibitors reduce cytokine levels, but not without significant side effects. Nutrition is a low-risk approach to reduce inflammation and ameliorate symptoms in MPN. We performed a randomized, parallel-arm study to determine the feasibility of an education-focused Mediterranean diet intervention among patients with MPN. Experimental Design: We randomly assigned patients with MPN to either a Mediterranean diet or standard U.S. Dietary Guidelines for Americans (USDA). Groups received equal but separate education with registered dietician counseling and written dietary resources. Patients were prospectively followed for feasibility, adherence, and symptom burden assessments. Biological samples were collected at four timepoints during the 15-week study to explore changes in inflammatory biomarkers and gut microbiome. Results: The Mediterranean diet was as easy to follow for patients with MPN as the standard USDA diet. Approximately 80% of the patients in the Mediterranean diet group achieved a Mediterranean Diet Adherence Score of ≥8 throughout the entire active intervention period, whereas less than 50% of the USDA group achieved a score of ≥8 at any timepoint. Improvement in symptom burden was observed in both diet groups. No significant changes were observed in inflammatory cytokines. The diversity and composition of the gut microbiome remained stable throughout the duration of the intervention. Conclusions: With dietician counseling and written education, patients with MPN can adhere to a Mediterranean eating pattern. Diet interventions may be further developed as a component of MPN care, and potentially incorporated into the management of other hematologic conditions. Significance: Diet is a central tenant of management of chronic conditions characterized by subclinical inflammation, such as cardiovascular disease, but has not entered the treatment algorithm for clonal hematologic disorders. Here, we establish that a Mediterranean diet intervention is feasible in the MPN patient population and can improve symptom burden. These findings warrant large dietary interventions in patients with hematologic disorders to test the impact of diet on clinical outcomes.
No Evidence of Hepatitis G Virus in Fulminant Hepatic Failure in Children
Perez, Roger G., Zein, Nizar N., Freese, Deborah K., Perrault, Jean J., Steers, Jeffery L., Sharp, Harvey L., Persing, David H., Perez, R G, Perrault, Jean

Journal of Pediatric Gastroenterology and Nutrition | February 23, 2024 | Volume: 28 | Issue: 4 | Pages: 400-403

10.1002/j.1536-4801.1999.tb02100.x Get It

ABSTRACTBackground:The cause of fulminant hepatic failure in children remains unknown, but a viral origin has been suspected in most cases. The recently discovered blood‐borne virus, hepatitis G, has been suggested as a possible causative agent.Method:Six consecutive children who underwent liver transplantation for fulminant hepatic failure were studied. The children were tested for hepatitis G virus antibodies and hepatitis G virus RNA by polymerase chain reaction after excluding other causes of fulminant hepatic failure.Results:No evidence of hepatitis G virus infection was found in these patients.Conclusion:Hepatitis G virus is unlikely to be a common cause of fulminant hepatic failure in pediatric patients from the upper midwestern United States.
Proton PBS Planning Techniques, Robustness Evaluation, and OAR Sparing for the Whole-Brain Part of Craniospinal Axis Irradiation
Matysiak, W , Landeweerd, Marieke C., Bannink, Agata , Weide, Hiska L. van der , Brouwer, Charlotte L. , Langendijk, Johannes A. , Both, Stefan , Maduro, John H. , Matysiak, Witold P , van der Weide, Hiska L , Gawryszuk, A.

Cancers | February 23, 2024 | Volume: 16 | Issue: 5 | Pages: 892

10.3390/cancers16050892 | PMID 38473254 Get It

Proton therapy is a promising modality for craniospinal irradiation (CSI), offering dosimetric advantages over conventional treatments. While significant attention has been paid to spine fields, for the brain fields, only dose reduction to the lens of the eye has been reported. Hence, the objective of this study is to assess the potential gains and feasibility of adopting different treatment planning techniques for the entire brain within the CSI target. To this end, eight previously treated CSI patients underwent retrospective replanning using various techniques: (1) intensity modulated proton therapy (IMPT) optimization, (2) the modification/addition of field directions, and (3) the pre-optimization removal of superficially placed spots. The target coverage robustness was evaluated and dose comparisons for lenses, cochleae, and scalp were conducted, considering potential biological dose increases. The target coverage robustness was maintained across all plans, with minor reductions when superficial spot removal was utilized. Single- and multifield optimization showed comparable target coverage robustness and organ-at-risk sparing. A significant scalp sparing was achieved in adults but only limited in pediatric cases. Superficial spot removal contributed to scalp V30 Gy reduction at the expense of lower coverage robustness in specific cases. Lens sparing benefits from multiple field directions, while cochlear sparing remains impractical. Based on the results, all investigated plan types are deemed clinically adoptable.
Impact of Deltoid Computer Tomography Image Data on the Accuracy of Machine Learning Predictions of Clinical Outcomes after Anatomic and Reverse Total Shoulder Arthroplasty
Rajabzadeh-Oghaz, Hamidreza , Berry, David B. , Singh, Anshu , Aibinder, William R. , Gobbato, Bruno , Polakovic, Sandrine , Elwell, Josie , Roche, Christopher , Berry, David B , Roche, Christopher P , Aibinder, William R , Kumar, Vikas , Schoch, Bradley S.

Journal of Clinical Medicine | February 23, 2024 | Volume: 13 | Issue: 5 | Pages: 1273

10.3390/jcm13051273 | PMID 38592118 Get It

Background: Despite the importance of the deltoid to shoulder biomechanics, very few studies have quantified the three-dimensional shape, size, or quality of the deltoid muscle, and no studies have correlated these measurements to clinical outcomes after anatomic (aTSA) and/or reverse (rTSA) total shoulder arthroplasty in any statistically/scientifically relevant manner. Methods: Preoperative computer tomography (CT) images from 1057 patients (585 female, 469 male; 799 primary rTSA and 258 primary aTSA) of a single platform shoulder arthroplasty prosthesis (Equinoxe; Exactech, Inc., Gainesville, FL) were analyzed in this study. A machine learning (ML) framework was used to segment the deltoid muscle for 1057 patients and quantify 15 different muscle characteristics, including volumetric (size, shape, etc.) and intensity-based Hounsfield (HU) measurements. These deltoid measurements were correlated to postoperative clinical outcomes and utilized as inputs to train/test ML algorithms used to predict postoperative outcomes at multiple postoperative timepoints (1 year, 2–3 years, and 3–5 years) for aTSA and rTSA. Results: Numerous deltoid muscle measurements were demonstrated to significantly vary with age, gender, prosthesis type, and CT image kernel; notably, normalized deltoid volume and deltoid fatty infiltration were demonstrated to be relevant to preoperative and postoperative clinical outcomes after aTSA and rTSA. Incorporating deltoid image data into the ML models improved clinical outcome prediction accuracy relative to ML algorithms without image data, particularly for the prediction of abduction and forward elevation after aTSA and rTSA. Analyzing ML feature importance facilitated rank-ordering of the deltoid image measurements relevant to aTSA and rTSA clinical outcomes. Specifically, we identified that deltoid shape flatness, normalized deltoid volume, deltoid voxel skewness, and deltoid shape sphericity were the most predictive image-based features used to predict clinical outcomes after aTSA and rTSA. Many of these deltoid measurements were found to be more predictive of aTSA and rTSA postoperative outcomes than patient demographic data, comorbidity data, and diagnosis data. Conclusions: While future work is required to further refine the ML models, which include additional shoulder muscles, like the rotator cuff, our results show promise that the developed ML framework can be used to evolve traditional CT-based preoperative planning software into an evidence-based ML clinical decision support tool.
Distinguishing Clinical From Statistical Significances in Contemporary Comparative Effectiveness Research
Gikandi, Ajami , Hallet, Julie , Koerkamp, Bas Groot , Lillemoe, Keith D. , Mamon, Harvey J. , Zenati, Marco A. , Wasif, Nabil , Safran, Dana Gelb , Traeger, Lara , Groot Koerkamp, Bas , Clark, Clancy J. , Narayan, Raja R. , Besselink, Marc G , Chang, David C. , Weissman, Joel S. , Fong, Zhi Ven

Annals of Surgery | February 23, 2024 | Volume: 279 | Issue: 6 | Pages: 907-912

10.1097/sla.0000000000006250 | PMID 38390761 Get It

Objective: To determine the prevalence of clinical significance reporting in contemporary comparative effectiveness research (CER). Background: In CER, a statistically significant difference between study groups may or may not be clinically significant. Misinterpreting statistically significant results could lead to inappropriate recommendations that increase health care costs and treatment toxicity. Methods: CER studies from 2022 issues of the Annals of Surgery , Journal of the American Medical Association , Journal of Clinical Oncology , Journal of Surgical Research , and Journal of the American College of Surgeons were systematically reviewed by 2 different investigators. The primary outcome of interest was whether the authors specified what they considered to be a clinically significant difference in the “Methods.” Results: Of 307 reviewed studies, 162 were clinical trials and 145 were observational studies. Authors specified what they considered to be a clinically significant difference in 26 studies (8.5%). Clinical significance was defined using clinically validated standards in 25 studies and subjectively in 1 study. Seven studies (2.3%) recommended a change in clinical decision-making, all with primary outcomes achieving statistical significance. Five (71.4%) of these studies did not have clinical significance defined in their methods. In randomized controlled trials with statistically significant results, sample size was inversely correlated with effect size ( r = −0.30, P = 0.038). Conclusions: In contemporary CER, most authors do not specify what they consider to be a clinically significant difference in study outcome. Most studies recommending a change in clinical decision-making did so based on statistical significance alone, and clinical significance was usually defined with clinically validated standards.